Company Filing History:
Years Active: 2012-2014
Title: Athos Gianella-Borradori: Innovator in Medical Treatments
Introduction
Athos Gianella-Borradori is a notable inventor based in Gauting, Germany. He has made significant contributions to the field of medicine, particularly in the development of treatments for autoimmune diseases and leukemia. With a total of 2 patents, his work is recognized for its potential impact on patient care.
Latest Patents
Gianella-Borradori's latest patents include innovative methods for treating autoimmune diseases and leukemia. One of his key inventions involves purine and pyrimidine CDK inhibitors, which are used to prepare medicaments for treating diseases associated with antinuclear antibodies. This invention focuses on the administration of CDK inhibitors to down-regulate antinuclear antibody levels, offering new hope for patients suffering from conditions like systemic lupus erythematosus (SLE). Another significant patent details methods of treatment using sapacitabine, a compound aimed at treating leukemia and myelodysplastic syndromes (MDS). This method outlines a specific dosing regimen that enhances the effectiveness of the treatment.
Career Highlights
Athos Gianella-Borradori is currently associated with Cyclacel Limited, a company known for its focus on innovative cancer therapies. His work at Cyclacel has allowed him to further develop his ideas and contribute to groundbreaking research in the medical field.
Collaborations
Gianella-Borradori collaborates with talented professionals such as Ariela Benigni and Carla Zoja. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.
Conclusion
Athos Gianella-Borradori is a distinguished inventor whose work in medical treatments is paving the way for advancements in healthcare. His patents reflect a commitment to improving patient outcomes and addressing critical health challenges.